Origin Bio

Founded by Yash Rathod

AI for safer cell & gene therapies

Cost

Demo

Rating

★ Mixed Reviews

Time to value

Requires Expertise

You can use Origin Bio to test how different drugs and treatments affect real patient tumor tissue. The company takes fresh tumor samples from surgery, slices them precisely while keeping the natural tumor environment intact, then tests various compounds like checkpoint inhibitors and chemotherapy drugs. They measure molecular responses using gene expression analysis, protein studies, and tissue examination. This data trains AI models to identify drug targets, screen compounds digitally, group patients by treatment response, and discover biomarkers for personalized cancer treatment.

What Origin Bio does

Collect fresh tumor tissue from surgical resectionsProcess tissue into precision-cut tumor slicesApply drug compounds to matched tissue samplesMeasure gene expression changes after treatmentAnalyze protein levels in treated tissueTrain machine learning models on response dataIdentify patterns in treatment effectivenessGenerate reports on compound activityTests compounds directly on fresh patient tumor tissuePreserves intact tumor microenvironment during testingRuns multiple molecular analysis panels simultaneouslyTrains AI models on perturbation-response dataCollects anonymized clinical annotations with samplesCreates precision-cut tumor slices for accurate testingGenerates transcriptomic and proteomic readoutsIdentifies drug targets through AI analysis